نتایج جستجو برای: non small cell lung cancer (nsclc)

تعداد نتایج: 4070744  

Journal: :international journal of hematology-oncology and stem cell research 0
m hoseinzadeh mollayosefy department of hematology and oncology, shariati hospital, school of medicine, tehran university of medical science, tehran, iran m iravani department of hematology and oncology, shariati hospital, school of medicine, tehran university of medical science, tehran, iran a ghavamzadeh department of hematology and oncology, shariati hospital, school of medicine, tehran university of medical science, tehran, iran gh toogheh deparment of hematology and oncology, emam khomeini (rah) hospital, school of medicine, tehran university of medical science, tehran, iran k alimoghaddam department of hematology and oncology, shariati hospital, school of medicine, tehran university of medical science, tehran, iran

background: cisplatin-based chemotherapy is the standard treatment for advanced non-small cell lung cancer (nsclc). many novel drugs, including gemcitabine, vinorelbine, paclitaxel and docetaxel have been used in combination with cisplatin in this setting. of these drugs, gemcitabine is reported to have a high response rate and acceptable toxicity. the aim of this study was to evaluate the effi...

Lung cancer is a very aggressive and most deadly cancer in both men and women. Lung cancer is divided into two types of small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC is divided into 3 subgroups: adenocarcinoma (AC), squamous cell carcinoma (SqCC) and large cell carcinoma (LCC). Dopamine is involved in controlling motions, cognition, emotions, memory and reward mech...

Journal: :iranian journal of immunology 0
sedigheh sharifzadeh department of laboratory science, paramedical school helmout modjtahedi postgraduate medical school, university of surrey, guildford, united–kingdom mahmood jedi tehrani avecina institute, tehran, iran abbas ghaderi department of immunology, shiraz university of medical sciences, shiraz, iran

background: lung carcinoma is a multiple type cancer comprising of small cell and non-small cell carcinomas (nsclc). for therapeutic and diagnostic purposes, serum monoclonal antibodies have been produced against lung cancer. objective: to charac-terize a murine monoclonal antibody (me3d11) reactive with human nsclc. methods: a murine monoclonal antibody (me3d11) reactive with human nsclc was s...

Journal: :iranian journal of pharmaceutical research 0
kian khodadad assistant professor of internal medicine, hematology and medical oncology, thoracic oncology department, chronic respiratory disease research center, national research institute of tuberculosis and lung disease adnan khosravi assistant professor of internal medicine, hematology and medical oncology zahra esfahani-monfared general physician, thoracic oncology department, chronic respiratory disease research center, nritld, masih daneshvari hospital, shahid beheshti university of medical sciences, tehran, iran shirin karimi associate professor of pathology, pathology department, mycobacteriology research center, nritld, masih daneshvari hospital, shahid beheshti university of medical sciences, tehran, iran sharare seifi assistant professor of internal medicine, hematology and medical oncology, thoracic oncology department, chronic respiratory disease research center, national research institute of tuberculosis and lung disease nritld, masih daneshvari hospital,

aims: the backbone of treatment in advanced non-small cell lung cancer is platinum-based doublet chemotherapy. we intended to compare the effectiveness of two commonly used regimens in real world practice. methods: this single institute, parallel comparative post marketing study included 100 patients with chemo-naïve advanced (stage iiib, iv) non-small cell lung cancer and eastern cooperative o...

Abbas Ghaderi, Helmout Modjtahedi Mahmood Jedi Tehrani Sedigheh Sharifzadeh,

Background: Lung carcinoma is a multiple type cancer comprising of small cell and non-small cell carcinomas (NSCLC). For therapeutic and diagnostic purposes, serum monoclonal antibodies have been produced against lung cancer. Objective: To charac-terize a murine monoclonal antibody (ME3D11) reactive with human NSCLC. Methods: A murine monoclonal antibody (ME3D11) reactive with human NSCLC was s...

Journal: :acta medica iranica 0
m. hoseinzadeh mollayosefy m. iravani a. ghavamzadeh g. toogheh k. alimoghadam

cisplatin-based chemotherapy is the standard treatment for advanced non-small cell lung cancer (nsclc). many novel drugs have been used in combination with cisplatin in this setting. of these drugs, gemcitabine is reported to have a high response rate and acceptable toxicity. the aim of this study was to evaluate the efficacy and safety of gemcitabine and cisplatin combination. twentythree pati...

ژورنال: پژوهش در پزشکی 2017

Background and Aim: Lung cancer is the most common cause of cancer-related deaths wordwide and non-small cell lung cancer (NSCLC), especially adenocarcinoma, is the most common type of lung cancer. Most cases of adenocarcinoma will occur due to KRAS mutations or EGFR mutations and amplifications. The polymorphism rs884225 which is associated with increased EGFR expression is located in the 3'UT...

Journal: :iranian journal of blood and cancer 0
mehrdad payandeh department of hematology and medical oncology, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) masoud sadeghi students research committee, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences) edris sadeghi students research committee, kermanshah university of medical sciences, kermanshah, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمانشاه (kermanshah university of medical sciences)

background: lung cancer is the most common cause of cancer death worldwide with an annual mortality rate of more than 1.3 million worldwide. we aimed to analyze the clinicopathological features of patients with non-small-cell lung cancer (nsclc) in west of iran. methods: 64 patients with nsclc who referred to our clinic were analyzed. sex, age, histopathology, location of the tumor, treatment, ...

Journal: :Journal of The National Comprehensive Cancer Network 2021

Updates to the NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) 2021 include recommendations biomarker testing in all appropriate patients with newly diagnosed advanced lung cancer, including squamous cell cancer. When a targetable genetic alteration is detected, recommend treatment first-line therapy targeted that alteration. The guidelines contain new information on use of adjuvant osim...

Background: Lung cancer is the most common cause of cancer death worldwide with an annual mortality rate of more than 1.3 million worldwide. We aimed to analyze the clinicopathological features of patients with non-small-cell lung cancer (NSCLC) in west of Iran. Methods: 64 patients with NSCLC who referred to our clinic were analyzed. Sex, age, histopathology, location of the tumor, treatment,...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید